Abiopharma

Nuwellis Announces Closing of $5.0 Million Underwritten Public Offering Including Full Exercise of Overallotment Option

XPro™ Reduces Amyloid and Enhances Behavior Post Traumatic Brain Injury in an Animal Model of Alz

Tilray Brands Stockholders Approve Reverse StockSplit; Company Pauses Implementation as It Evaluates Timing and Stock Price

The Joint Corp. Names Business Transformation and GrowthExpert Scott J. Bowman Chief Financial Officer

Illumina, Inc. - lllumina releases 2024 Corporate Social Responsibility Report as it advances its vision to unlock the power of genomics

Celldex Announces Upcoming Presentations of Barzolvolimab Phase 2 Data in Chronic Spontaneous Urticaria at EAACI 2025 Congress

lllumina releases 2024 Corporate Social Responsibility Report as it advances its vision to unlock the power of genomics

Inventiva Annonce la Nomination de Renée Aguiar-Lucander à son Conseil d’Administration

Inventiva Announces the Appointment of Renée Aguiar-Lucander to its Board of Directors

XPro™ Reduces Amyloid and Enhances Behavior Post Traumatic Brain Injury in an Animal Model of Alzheimer’s Disease: Supported by Department of Defense